The burden of neurological diseases is increasing. The numbers of patients having dementias, Parkinson's disease, strokes, and other age-linked diseases is expected to increase exponentially. Our ambition is to stop, reverse, and cure these diseases by delivering innovative, life-changing medicines and solutions for patients.India is home to 10 - 12 million people with epilepsy with wide treatment gaps. Similarly, a 100 percent increase in stroke prevalence in low and middle- income countries (LMIC) including India has been reported in the past two decades, and only about 10% of stroke patients get thrombolysis in the first 4.5 hours. Allites is an innovation-driven company that provides a differentiated approach to target unmet medical needs.